Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,119
Closed -$2.88M 81
2022
Q2
$2.88M Buy
6,119
+92
+2% +$44.9K 1.02% 26
2022
Q1
$3.06M Hold
6,027
0.86% 31
2021
Q4
$3.19M Buy
6,027
+1,267
+27% +$608K 0.93% 31
2021
Q3
$2.25M Sell
4,760
-1,312
-22% -$619K 0.88% 29
2021
Q2
$2.89M Buy
6,072
+1,602
+36% +$769K 1.06% 21
2021
Q1
$2.06M Buy
4,470
+104
+2% +$51K 0.78% 34
2020
Q4
$2.29M Buy
4,366
+89
+2% +$43.7K 0.9% 26
2020
Q3
$2.04M Buy
4,277
+42
+1% +$20.6K 1.03% 29
2020
Q2
$1.88M Sell
4,235
-2,174
-34% -$971K 0.9% 27
2020
Q1
$2.76M Sell
6,409
-745
-10% -$333K 1.35% 10
2019
Q4
$2.96M Hold
7,154
1.67% 11
2019
Q3
$2.96M Sell
7,154
-189
-3% -$77.2K 1.67% 11
2019
Q2
$2.62M Buy
7,343
+808
+12% +$270K 1.46% 17
2019
Q1
$2.1M Buy
6,535
+170
+3% +$52.2K 1.11% 22
2018
Q4
$1.79M Buy
+6,365
New +$1.92M 1.05% 19

Other funds holding CHE

Ninety One's CHE Position: Q3 2022 in Review

Ninety One sold out of Chemed (CHE) in Q3 2022, closing a stake of 6,119 shares — an estimated $2.88M sold.

Ninety One first reported a position in CHE in Q4 2018 and held it in 15 quarters. The position peaked at $3.19M in Q4 2021. 419 funds tracked by Wall St. Rank hold CHE as of Q3 2022.

  • Ninety One reported no remaining Chemed position as of Q3 2022 after selling out during the quarter.
  • Ninety One sold 6,119 Chemed shares in Q3 2022, an estimated $2.88M.
  • Ninety One first reported a position in Chemed in Q4 2018 and held it in 15 quarters.
  • Ninety One's Chemed position peaked at $3.19M in Q4 2021.
  • 419 funds tracked by Wall St. Rank held Chemed as of Q3 2022.

Based on Ninety One's 13F filing for Q3 2022, filed 14 Nov 2022.